Please login to the form below

Not currently logged in
Email:
Password:

Portland Health wins Mundipharma account

Handling communications for the pain, oncology and asthma specialist

Portland Health, the recently launched healthcare arm of Portland Communications, has been appointed by Mundipharma International to handle its corporate communications.

The Cambridge, UK-based pharmaceutical company is structured as a network of independent associated companies, consisting of privately owned businesses and joint ventures. Together they have a focus on therapy areas including pain, oncology, rheumatoid arthritis and respiratory.

High on the Portland Health's agenda will be to raise the profile of the recently launched asthma drug Flutiform (fluticasone/formoterol).

In addition, the comms agency will also be tasked with driving more general awareness of Mundipharma, as it looks to expand across Europe, in terms of employees, potential clients and partnerships.

"Mundipharma's way of doing business is groundbreaking in today's market,” explained Louise Fish, the recently appointed head of Portland Health.

"We're excited to be part of their journey and look forward to helping them to build on the success they have already achieved."

Fish will report to Georg Toufar, chief marketing officer and board director at Mundipharma, who said: "Mundipharma International is a success story worth telling.

"We are bringing new treatments to the European market to benefit patients and our business model means we achieve value for payers at the same time.

"We're delighted to be working with Portland to tell this story to the best and brightest people and businesses in the pharma industry throughout Europe."

17th April 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics